Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer-Reference-Cited by-同舟云学术

Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer

Published:2010-02-05 Issue:1 Volume:8 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Riccardi Ferdinando,Di Lorenzo Giuseppe,Buonerba Carlo,Monaco Guglielmo,Monaco Roberto,Rizzo Mimma,Scagliarini Sarah,Scognamiglio Florinda,Di Napoli Marilena,Carteni' Giacomo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/1477-7819-8-8.pdf

Reference8 articles.

1. Albain KS: Induction therapy followed by definitive local control for stage III non-small-cell lung cancer. A review, with a focus on recent trimodality trials. Chest. 1993, 103 (Suppl): 43-50S. 10.1378/chest.103.1_Supplement.43S.

2. Eberhardt W, Gauler T, Pöttgen C, Krbek T, Korfee S, Stamatis G, Stuschke M: Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer. J Thorac Oncol. 2007, 2 (5 Suppl): S35-6. 10.1097/01.JTO.0000268640.56073.d1.

3. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarié E, Gouva S, Paillot N, Bréchot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchâtre M, Coëtmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C, French Thoracic Cooperative Group: Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol. 2002, 20: 247-53. 10.1200/JCO.20.1.247.

4. Delbaldo C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon JP: Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis. JAMA. 2004, 292: 470-84. 10.1001/jama.292.4.470.

5. Mattson KV, Abratt RP, ten Velde G, Krofta K: Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study. Ann Oncol. 2003, 14: 116-22. 10.1093/annonc/mdg009.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Preoperative Radiotherapy Versus Chemoradiotherapy in Advanced Rectal Cancer: A Meta-analysis of Randomized Controlled Trials;The American Surgeon;2022-04-17

2. Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients;International Journal of Clinical Oncology;2011-08-19